{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:11:00Z","timestamp":1787148660440,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1163961"],"award-info":[{"award-number":["1163961"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","award":["ACTRN12621000871842"],"award-info":[{"award-number":["ACTRN12621000871842"]}],"id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","award":["HREC 27616"],"award-info":[{"award-number":["HREC 27616"]}],"id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003072","name":"LOEWE Zentrum AdRIA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.sapharm.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T03:22:26Z","timestamp":1637205746000},"page":"3394-3401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A prospective, multisite implementation-efficacy trial of a collaborative prescriber-pharmacist model of care for Medication Assisted Treatment for Opioid Dependence: Protocol for the EPIC-MATOD study"],"prefix":"10.1016","volume":"18","author":[{"given":"Suzanne","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3514-8702","authenticated-orcid":false,"given":"John","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-2531","authenticated-orcid":false,"given":"Dennis","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-2501","authenticated-orcid":false,"given":"David","family":"Jacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Picco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2021.11.007_bib1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","volume":"24","author":"Ma","year":"2019","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.sapharm.2021.11.007_bib2","series-title":"Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines","author":"Mattick","year":"2009"},{"key":"10.1016\/j.sapharm.2021.11.007_bib3","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2021.11.007_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2016.09.008","article-title":"Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam","volume":"168","author":"Vuong","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2021.11.007_bib5","series-title":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 IEWG. Drug Misuse and Dependence: UK Guidelines on Clinical Management","year":"2017"},{"key":"10.1016\/j.sapharm.2021.11.007_bib6","first-page":"671","article-title":"Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment","volume":"27","author":"Madden","year":"2008"},{"key":"10.1016\/j.sapharm.2021.11.007_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00019053-200826050-00003","article-title":"Economic evaluation of interventions to treat opiate dependence","volume":"26","author":"Doran","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.sapharm.2021.11.007_bib8","unstructured":"Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N. National Guidelines for Medication-Assisted Treatment of Opioid Dependence 2014."},{"key":"10.1016\/j.sapharm.2021.11.007_bib9","doi-asserted-by":"crossref","first-page":"108464","DOI":"10.1016\/j.drugalcdep.2020.108464","article-title":"Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001\u20132018: implications for treatment systems and potential impact on client outcomes","volume":"219","author":"Jones","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2021.11.007_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/dar.12979","article-title":"The lived experience of Australian opioid replacement therapy recipients in a community\u2010based program in regional Victoria","volume":"38","author":"Patil Vishwanath","year":"2019","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2021.11.007_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11469-018-9936-2","article-title":"A narrative review of pharmacotherapy treatment for opioid addiction and application in a community-based model in Victoria, Australia","volume":"18","author":"Vishwanath","year":"2020","journal-title":"Int J Ment Health Addiction"},{"issue":"Supplement","key":"10.1016\/j.sapharm.2021.11.007_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15288\/jsads.2019.s18.42","article-title":"Measuring unmet demand for alcohol and other drug treatment: the application of an Australian population-based planning model","author":"Ritter","year":"2019","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.sapharm.2021.11.007_bib13","doi-asserted-by":"crossref","first-page":"108011","DOI":"10.1016\/j.jsat.2020.108011","article-title":"Appointment wait-times and arrival for patients at a low-barrier access addiction clinic","volume":"114","author":"Roy","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.sapharm.2021.11.007_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archpsyc.63.1.102","article-title":"A randomized controlled trial of interim methadone maintenance","volume":"63","author":"Schwartz","year":"2006","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.sapharm.2021.11.007_bib15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/eurpub\/ckw098","article-title":"Task shifting from physicians to nurses in primary care in 39 countries: a cross-country comparative study","volume":"26","author":"Maier","year":"2016","journal-title":"Eur J Publ Health"},{"key":"10.1016\/j.sapharm.2021.11.007_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jppr.1619","article-title":"Systematic review of expanded practice in rural community pharmacy","volume":"49","author":"Taylor","year":"2019","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.sapharm.2021.11.007_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.healthpol.2015.02.007","article-title":"From \u201cretailers\u201d to health care providers: transforming the role of community pharmacists in chronic disease management","volume":"119","author":"Mossialos","year":"2015","journal-title":"Health Pol"},{"key":"10.1016\/j.sapharm.2021.11.007_bib18","volume":"vol. 16","author":"Murray","year":"2016"},{"key":"10.1016\/j.sapharm.2021.11.007_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jac5.1171","article-title":"Pharmacists and the opioid crisis: a narrative review of pharmacists' practice roles","volume":"3","author":"Bratberg","year":"2020","journal-title":"J Am Coll Clinic Pharm"},{"key":"10.1016\/j.sapharm.2021.11.007_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1331\/JAPhA.2015.14177","article-title":"Physician\u2013pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients","volume":"55","author":"DiPaula","year":"2015","journal-title":"J Am Pharmaceut Assoc"},{"key":"10.1016\/j.sapharm.2021.11.007_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.sapharm.2017.02.017","article-title":"Collaborative pharmacist prescribing within the opioid substitution treatment program in South Australia: patient and pharmacist views","volume":"14","author":"Le","year":"2018","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2021.11.007_bib22","series-title":"Developing a Collaborative-care Model for Delivering Medication Assisted Treatment for Opioid Dependence (MATOD): understanding Pharmacist, Prescriber and Consumer Perceptions","author":"Cheetham","year":"2021"},{"key":"10.1016\/j.sapharm.2021.11.007_bib23","series-title":"National Opioid Pharmacotherapy Statistics Annual Data Collection","year":"2021"},{"key":"10.1016\/j.sapharm.2021.11.007_bib24","series-title":"Policy for Maintenance Pharmacotherapy for Opioid Dependence","year":"2016"},{"key":"10.1016\/j.sapharm.2021.11.007_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"10.1016\/j.sapharm.2021.11.007_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-9-39","article-title":"Expert recommendations for implementing change (ERIC): protocol for a mixed methods study","volume":"9","author":"Waltz","year":"2014","journal-title":"Implement Sci"},{"key":"10.1016\/j.sapharm.2021.11.007_bib27","series-title":"The Australian Statistical Geography Standard (ASGS) Remoteness Structure","year":"2018"},{"key":"10.1016\/j.sapharm.2021.11.007_bib28","series-title":"National Guidelines for Medication-Assisted Treatment of Opioid Dependence","author":"Gowing","year":"2014"},{"key":"10.1016\/j.sapharm.2021.11.007_bib29","series-title":"Sage Handbook of Mixed Methods in Social and Behavioral Research","first-page":"209","article-title":"Advances in mixed methods research designs","author":"Creswell","year":"2003"},{"key":"10.1016\/j.sapharm.2021.11.007_bib30","doi-asserted-by":"crossref","first-page":"112630","DOI":"10.1016\/j.psychres.2019.112630","article-title":"Reprint of: an introduction to effectiveness-implementation hybrid designs","volume":"283","author":"Landes","year":"2020","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.sapharm.2021.11.007_bib31","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.sapharm.2021.11.007_bib32","article-title":"Retention of patients in opioid substitution treatment: a systematic review","volume":"15","author":"O'Connor","year":"2020","journal-title":"PLoS One"},{"issue":"00","key":"10.1016\/j.sapharm.2021.11.007_bib33","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/add.15514","article-title":"The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15\u2010year retrospective cohort study","volume":"116","author":"Bharat","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2021.11.007_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/dar.12083","article-title":"Validation and implementation of the A ustralian Treatment Outcomes Profile in specialist drug and alcohol settings","volume":"33","author":"Ryan","year":"2014","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2021.11.007_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jval.2011.11.035","article-title":"The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF","volume":"15","author":"da Rocha","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.sapharm.2021.11.007_bib36","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.sapharm.2021.11.007_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/16066350009005590","article-title":"Assessing client satisfaction with treatment for substance use problems and the development of the Treatment Perceptions Questionnaire (TPQ)","volume":"8","author":"Marsden","year":"2000","journal-title":"Addiction Res"},{"key":"10.1016\/j.sapharm.2021.11.007_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5195\/jmla.2018.319","article-title":"Research electronic data capture (REDCap)","volume":"106","author":"Patridge","year":"2018","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.sapharm.2021.11.007_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.sapharm.2021.11.007_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/add.13314","article-title":"Iterative categorization (IC): a systematic technique for analysing qualitative data","volume":"111","author":"Neale","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2021.11.007_bib41","first-page":"346","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2021.11.007_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drugalcdep.2015.02.004","article-title":"Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011","volume":"149","author":"Nielsen","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2021.11.007_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/14659891.2018.1523968","article-title":"\u201cA lot of people call it liquid handcuffs\u201d\u2013barriers and enablers to opioid replacement therapy in a rural area","volume":"24","author":"Wood","year":"2019","journal-title":"J Subst Use"},{"key":"10.1016\/j.sapharm.2021.11.007_bib44","series-title":"Polygon: The Many Sides to the Australian Opioid Pharmacotherapy Maintenance System","author":"Ritter","year":"2009"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112100379X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112100379X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:28:45Z","timestamp":1761557325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112100379X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S155174112100379X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.11.007","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective, multisite implementation-efficacy trial of a collaborative prescriber-pharmacist model of care for Medication Assisted Treatment for Opioid Dependence: Protocol for the EPIC-MATOD study","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}